NVDA Q3 Earnings Alert: Why our AI stock picker is still holding Nvidia stockRead More

AdaptHealth shares plummet 14% as guidance disappoints

EditorRachael Rajan
Published 11/05/2024, 09:06 PM
© Reuters.
AHCO
-

PLYMOUTH MEETING, Pa. - AdaptHealth Corp. (NASDAQ:AHCO) reported third-quarter earnings that missed analyst expectations and lowered its full-year outlook, sending shares plunging 14% in early trading Tuesday.

The provider of home medical equipment and supplies posted adjusted earnings per share of $0.15 for the quarter ended September 30, falling short of the $0.19 consensus estimate. Revenue came in at $805.9 million, slightly below Wall Street's projection of $809.32 million but up 0.2% YoY.

AdaptHealth lowered its full-year 2024 revenue guidance to a range of $3.22 billion to $3.26 billion, down from its previous forecast of $3.255 billion to $3.315 billion. The new outlook falls short of analysts' expectations of $3.28 billion.

"I continue to be optimistic about the road ahead. We have identified growth opportunities, we are assembling a high performing team and investing in areas that allow us to serve even more patients in their homes," said CEO Suzanne Foster.

The company reported net income of $22.9 million for the quarter, compared to a net loss of $454.1 million in the same period last year. Adjusted EBITDA rose 1.9% YoY to $164.3 million.

AdaptHealth also noted that it completed the sale of certain custom rehab assets during the quarter.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.